Literature DB >> 1759904

Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera.

J C Hierholzer1, Y O Stone, J R Broderson.   

Abstract

Reference equine antisera to all 47 serotypes of human adenoviruses presently described have been prepared and evaluated by reciprocal neutralization and hemagglutination-inhibition tests. All tests were carried to endpoint dilutions a minimum of five times in each direction to give accurate values for homologous and heterologous antibody titers. Significant cross-reactions in the horse antisera were compared to similar data obtained from rabbit antisera. Using this analysis, major antigenic relationships exist among types 12-18-31 of subgenus A, types 7-11-14 and 34-35 of subgenus B, types 8-9-10, 10-19-37, 13-38-39, 15-22-42, 20-47, 24-32-33-46, and 29-45 of subgenus D, types 16-4 between subgenera B and E, and types 40-41 of subgenus F. Across all subgenera, types 8, 10, 13, 15, 17, 19, 26, 29, 39, 40, and 43 have antigenic moieties found most frequently in other types, averaging 12 heterologous reactions per type when summing both tests in both directions. Types 20, 30, 32, and 45 exhibit shared determinants slightly less often, with a mean of 8 heterologous reactions per type.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1759904     DOI: 10.1007/bf01316753

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  65 in total

1.  Examination of uncommon clinical isolates of human adenoviruses by restriction endonuclease analysis.

Authors:  G W Hammond; G Mauthe; J Joshua; C K Hannan
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

2.  Sequence and genetic organization of adenovirus type 35 early region 3.

Authors:  P R Flomenberg; M Chen; M S Horwitz
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Further subgrouping of the human adenoviruses by differential hemagglutination.

Authors:  J C Hierholzer
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

4.  Molecular epidemiology of adenoviral conjunctivitis in Sapporo, Japan, and Manila, the Philippines.

Authors:  H Sawada; K Aoki; R Kawana; I Matsumoto; M Shinagawa; D F Guo; R V Fajardo
Journal:  Jpn J Ophthalmol       Date:  1987       Impact factor: 2.447

5.  Characterization of candidate adenovirus 37 by SDS-polyacrylamide gel electrophoresis of virion polypeptides and DNA restriction site mapping.

Authors:  G Wadell; G Sundell; J C de Jong
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

6.  Epidemic adenovirus keratoconjunctivitis.

Authors:  A B Tullo; P G Higgins
Journal:  Lancet       Date:  1978-02-25       Impact factor: 79.321

7.  Fatal disseminated adenovirus infection in a renal transplant recipient.

Authors:  R L Myerowitz; H Stalder; M N Oxman; M J Levin; M Moore; J D Leith; N M Gantz; J C Hierholzer; J C Hierholzer
Journal:  Am J Med       Date:  1975-10       Impact factor: 4.965

8.  A new human adenovirus of subgenus D: candidate adenovirus type 42.

Authors:  R Wigand; T Adrian; F Bricout
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

9.  Viral conjunctivitis with special reference to adenovirus type 37 and enterovirus 70 infection.

Authors:  K Aoki; R Kawana; I Matsumoto; G Wadell; J C de Jong
Journal:  Jpn J Ophthalmol       Date:  1986       Impact factor: 2.447

10.  Keratoconjunctivitis associated with adenovirus type 37: an extended outbreak in an ophthalmologist's office.

Authors:  R A Keenlyside; J C Hierholzer; L J D'Angelo
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

View more
  39 in total

1.  Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.

Authors:  Mieke C Sprangers; Wandena Lakhai; Wouter Koudstaal; Marielle Verhoeven; Björn F Koel; Ronald Vogels; Jaap Goudsmit; Menzo J E Havenga; Stefan Kostense
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Complete genome sequence of human adenovirus prototype 17.

Authors:  Shoaleh Dehghan; Jason Seto; Nolan R Hudson; Christopher M Robinson; Morris S Jones; David W Dyer; James Chodosh; Donald Seto
Journal:  J Virol       Date:  2011-11       Impact factor: 5.103

3.  Multiplex PCR assay for rapid identification of oculopathogenic adenoviruses by amplification of the fiber and hexon genes.

Authors:  Urmila Banik; Arun Kumar Adhikary; Eiko Suzuki; Toshiki Inada; Nobuhiko Okabe
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

4.  Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.

Authors:  Ijad Madisch; Gabi Harste; Heidi Pommer; Albert Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Antigenic homogeneity among the adenovirus hexon types of subgenus C.

Authors:  E Adám; I Nász; A Lengyel
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Circumvention of immunity to the adenovirus major coat protein hexon.

Authors:  S Roy; P S Shirley; A McClelland; M Kaleko
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  Rapid subgenus identification of human adenovirus isolates by a general PCR.

Authors:  A H Kidd; M Jonsson; D Garwicz; A E Kajon; A G Wermenbol; M W Verweij; J C De Jong
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

8.  Characterization of adenovirus hexons by their epitope composition.

Authors:  E Adám; I Nász; A Lengyel
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy.

Authors:  Zenaido T Camacho; Mallory A Turner; Michael A Barry; Eric A Weaver
Journal:  Hum Gene Ther       Date:  2014-04-10       Impact factor: 5.695

10.  Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods.

Authors:  John J Rux; Paula R Kuser; Roger M Burnett
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.